Etilevodopa hydrochloride
CAS No. 39740-30-2
Etilevodopa hydrochloride ( Etilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester )
产品货号. M27765 CAS No. 39740-30-2
盐酸艾替沃多巴是左旋多巴的前药。它还具有更大的胃溶解度和显着的脑渗透性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥275 | 有现货 |
|
| 10MG | ¥471 | 有现货 |
|
| 25MG | ¥918 | 有现货 |
|
| 50MG | ¥1535 | 有现货 |
|
| 100MG | ¥2385 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Etilevodopa hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述盐酸艾替沃多巴是左旋多巴的前药。它还具有更大的胃溶解度和显着的脑渗透性。
-
产品描述Etilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
体外实验Etilevodopa (L-Dopa ethyl ester) hydrochloride passes unchanged through the stomach to the duodenum, where it is rapidly hydrolyzed by local esterases to Levodopa and ethanol, and is subsequently absorbed into the blood stream as Levodopa.Compared with standard Levodopa, Etilevodopa hydrochloride has greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration.
-
体内实验——
-
同义词Etilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester
-
通路Others
-
靶点Other Targets
-
受体nNOS/NOS1 AP
-
研究领域——
-
适应症——
化学信息
-
CAS Number39740-30-2
-
分子量261.7
-
分子式C11H16ClNO4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 125 mg/mL (477.65 mM)
-
SMILESCl.CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Wan-Hung Lee, et al. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Mol Pain. 2018 Jan-Dec;14:1744806918801224.
产品手册
关联产品
-
Procyanidin B2 3,3-d...
Procyanidin B2 3,3-di-O-gallate
-
AM966
AM966 是一种优异的亲和力、特异性、口服 LPA1 (IC50=17 nM) 拮抗剂,可抑制 LPA 刺激的细胞内钙释放。
-
Glofitamab
Glofitamab (RO7082859) 是一种与 T 细胞结合的双特异性抗体,具有新颖的 2:1 结构,B 细胞上的CD20 为二价,T 细胞上的 CD3 为一价。Glofitamab 与恶性细胞上的 CD20 结合后,可导致 T 细胞活化、增殖和肿瘤细胞杀伤。Glofitamab 可诱导复发或难治性 B 细胞淋巴瘤的持久完全缓解。
021-51111890
购物车()
sales@molnova.cn

